Edition:
India

Aerpio Pharmaceuticals Says Stephen Hoffman Departed His Positions As CEO, Principal Executive Officer Of Co, Effective Immediately


Saturday, 19 Oct 2019 

Oct 18 (Reuters) - Aerpio Pharmaceuticals Inc ::AERPIO PHARMACEUTICALS-ON OCT 15, STEPHEN HOFFMAN DEPARTED HIS POSITIONS AS CEO OF CO AND AS PRINCIPAL EXECUTIVE OFFICER OF CO, EFFECTIVE IMMEDIATELY.AERPIO PHARMACEUTICALS INC - ON OCT 15, HOFFMAN ALSO RESIGNED AS A DIRECTOR OF CO, EFFECTIVE IMMEDIATELY.AERPIO PHARMACEUTICALS - ON OCT 15, MICHAEL ROGERS DEPARTED AS CHIEF FINANCIAL AND BUSINESS OFFICER OF CO AND AS PRINCIPAL FINANCIAL OFFICER OF CO.AERPIO PHARMACEUTICALS-APPOINTED JOSEPH GARDNER, CURRENT PRESIDENT AND FOUNDER, AS CO'S PRINCIPAL EXECUTIVE OFFICER ON OCT 15, EFFECTIVE IMMEDIATELY.AERPIO PHARMACEUTICALS - APPOINTED REGINA MAREK,CURRENT VICE PRESIDENT OF FINANCE AS CO'S PRINCIPAL FINANCIAL OFFICER,PRINCIPAL ACCOUNTING OFFICER. 

Company Quote

0.627
0.0046 +0.74%
22 Jan 2020